Biotx.ai

Berlin, Germany

    Biotx.ai

    2017

    Clinical datasets are difficult to analyze using standard reported machine learning approaches, due to their small samples and many features. Biotx.ai provides highly sophisticated machine learning used for biomedical drug development by identifying significant patterns in biomedical datasets.

    Co-founders: Dr. Joern Klinger & Dr. Marco Schmidt

    Demo Day deck